Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurti, K.-
dc.contributor.authorButler, L.-
dc.contributor.authorSakko, A.-
dc.contributor.authorRicciardelli, C.-
dc.contributor.authorMitto, T.-
dc.contributor.authorOctnick, A.-
dc.contributor.authorStahl, J.-
dc.contributor.authorTilley, W.-
dc.identifier.citationMedical Journal of Indonesia, 2010; 19(1):5-13-
dc.description.abstractAim To construct tissue microarrays (TMAs) that consisted of prostate tumours from the transgenic adenocarcinoma of mouse prostate (TRAMP) mice and non-transgenic murine prostates and to assess androgen receptor (AR) levels during progression of prostate cancer in TRAMP mice by immunohistochemistry. Methods Haematoxylin and eosin (H&E) sections from the ventral and dorso-lateral prostate lobes of non-transgenic, intact TRAMP and castrated TRAMP were used to demarcate regions of interest for TMAs construction. The samples on TMAs were used to evaluate AR expression using video image analysis (VIA). Results AR was expressed during cancer progression, but AR levels were reduced or absent in late stage disease. Furthermore, when AR levels were compared in tumours from intact and castrate animals, a significant increase in AR levels was observed following androgen ablation. Conclusion Similar to clinical prostate cancer, in the TRAMP model, prostate tumours evolve mechanisms to maintain AR expression and AR responsive gene pathways following castration to facilitate continued tumour growth.-
dc.description.statementofresponsibilityKrisna Murti, Lisa M. Butler, Andrew Sakko, Carmela Ricciardelli, Tina B. Mitto, Alexandra Octnick, Jurgen Stahl, Wayne D. Tilley-
dc.publisherFaculty of Medicine Universitas Indonesia-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.-
dc.subjectAndrogen ablation therapy; tissue microarrays; haematoxylin and eosin; video image analysis-
dc.titleAndrogen receptor levels during progression of prostate cancer in the transgenic adenocarcinoma of mouse prostate model-
dc.typeJournal article-
dc.identifier.orcidButler, L. [0000-0003-2698-3220]-
dc.identifier.orcidRicciardelli, C. [0000-0001-7415-1854]-
dc.identifier.orcidTilley, W. [0000-0003-1893-2626]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_119760.pdfPublished Version1.08 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.